Related Experiment Video
Updated: Sep 26, 2025
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Application of High-Throughput Imaging Mass Cytometry Hyperion in Cancer Research
Marion Le Rochais1,2, Patrice Hemon1, Jacques-Olivier Pers1
1B Lymphocytes, Autoimmunity and Immunotherapies, UMR1227, Immunology Department, Augustin Morvan Hospital, Brest, France.
Insights
Imaging mass cytometry (IMC) provides in situ cell analysis within tissue architecture. This method aids in discovering cancer biomarkers and understanding treatment resistance for improved cancer research.
Area of Science:
- Biomedical Engineering
- Immunology
- Oncology
Background:
- Imaging mass cytometry (IMC) allows in situ cellular analysis within intact tissue architecture.
- IMC enables simultaneous detection of up to 50 protein markers using metal-conjugated antibodies.
- Understanding cellular interactions in the tumor microenvironment is crucial for cancer research.
Purpose of the Study:
- To review the applications of IMC in cancer research.
- To present the IMC method, detailing its advantages and limitations.
- To highlight IMC's potential in defining prognostic and theranostic biomarkers and understanding cancer progression.
Main Methods:
- Literature review of IMC applications in cancer studies.
- Detailed explanation of the IMC methodology.
- Comparative analysis of IMC with other tissue analysis methods.
Main Results:
- IMC facilitates in-depth phenotyping of cells in their native microenvironment.
- The technology supports the identification of biomarkers for cancer prognosis and treatment.
- IMC aids in elucidating cancer progression and immune resistance mechanisms.
Conclusions:
- IMC is a powerful tool for deciphering the complexity of cancer tissue.
- The method holds significant potential for advancing cancer diagnostics and therapeutics.
- Further research utilizing IMC can enhance our understanding and treatment of cancer.
Abstract:
Imaging mass cytometry (IMC) enables the in situ analysis of in-depth-phenotyped cells in their native microenvironment within the preserved architecture of a single tissue section. To date, it permits the simultaneous analysis of up to 50 different protein- markers targeted by metal-conjugated antibodies. The application of IMC in the field of cancer research may notably help 1) to define biomarkers of prognostic and theragnostic significance for current and future treatments against well-established and novel therapeutic targets and 2) to improve our understanding of cancer progression and its resistance mechanisms to immune system and how to overcome them. In the present article, we not only provide a literature review on the use of the IMC in cancer-dedicated studies but we also present the IMC method and discuss its advantages and limitations among methods dedicated to deciphering the complexity of cancer tissue.
